|
1
|
Becchetti C, Gschwend SG, Dufour JF and
Banz V: COVID-19 in liver transplant recipients: A systematic
review. J Clin Med. 10(4015)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sripongpun P, Pinpathomrat N, Bruminhent J
and Kaewdech A: Coronavirus disease 2019 vaccinations in patients
with chronic liver disease and liver transplant recipients: An
update. Front Med (Lausanne). 9(924454)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Azzi Y, Bartash R, Scalea J, Loarte-Campos
P and Akalin E: COVID-19 and solid organ transplantation: A review
article. Transplantation. 105:37–55. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Raja MA, Mendoza MA, Villavicencio A,
Anjan S, Reynolds JM, Kittipibul V, Fernandez A, Guerra G, Camargo
JF, Simkins J, et al: COVID-19 in solid organ transplant
recipients: A systematic review and meta-analysis of current
literature. Transplant Rev (Orlando). 35(100588)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Goldman JD, Robinson PC, Uldrick TS and
Ljungman P: COVID-19 in immunocompromised populations: Implications
for prognosis and repurposing of immunotherapies. J Immunother
Cancer. 9(e002630)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kates OS, Haydel BM, Florman SS, Rana MM,
Chaudhry ZS, Ramesh MS, Safa K, Kotton CN, Blumberg EA, Besharatian
BD, et al: Coronavirus disease 2019 in solid organ transplant: A
multicenter cohort study. Clin Infect Dis. 73:e4090–e4099.
2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dufour JF, Marjot T, Becchetti C and Tilg
H: COVID-19 and liver disease. Gut. 71:2350–2362. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee
MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, et al: Efficacy
of covid-19 vaccines in immunocompromised patients: Systematic
review and meta-analysis. BMJ. 376(e068632)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cornberg M, Buti M, Eberhardt CS, Grossi
PA and Shouval D: EASL position paper on the use of COVID-19
vaccines in patients with chronic liver diseases, hepatobiliary
cancer and liver transplant recipients. J Hepatol. 74:944–951.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fix OK, Blumberg EA, Chang KM, Chu J,
Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, et al:
American association for the study of liver diseases expert panel
consensus statement: Vaccines to prevent coronavirus disease 2019
infection in patients with liver disease. Hepatology. 74:1049–1064.
2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Interim Clinical Considerations for Use of
COVID-19 Vaccines Currently Authorized in the United States.
https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html
(Accessed on December 13, 2022).
|
|
12
|
Feikin DR, Higdon MM, Abu-Raddad LJ,
Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL,
Smith PG, et al: Duration of effectiveness of vaccines against
SARS-CoV-2 infection and COVID-19 disease: Results of a systematic
review and meta-regression. Lancet. 399:924–944. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Danziger-Isakov L and Kumar D: AST ID
Community of Practice. Vaccination of solid organ transplant
candidates and recipients: Guidelines from the American society of
transplantation infectious diseases community of practice. Clin
Transplant. 33(e13563)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yoo JJ, Yon DK, Lee SW, Shin JI and Kim
BK: Humoral immunogenicity to SARS-CoV-2 vaccination in liver
transplant recipients: A systematic review and meta-analysis. Int J
Biol Sci. 18:5849–5857. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cheung KS, Mok CH, Mao X, Zhang R, Hung
IF, Seto WK and Yuen MF: COVID-19 vaccine immunogenicity among
chronic liver disease patients and liver transplant recipients: A
meta-analysis. Clin Mol Hepatol. 28:890–911. 2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tang K, Wu X, Luo Y, Wei Z, Feng L and Wu
L: Meta-analysis of immunologic response after COVID-19 mRNA
vaccination in solid organ transplant recipients. J Infect.
84:e73–e75. 2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Meshram HS, Kute V, Rane H, Dave R,
Banerjee S, Mishra V and Chauhan S: Humoral and cellular response
of COVID-19 vaccine among solid organ transplant recipients: A
systematic review and meta-analysis. Transpl Infect Dis.
24(e13926)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen X, Luo D, Mei B, Du J, Liu X, Xie H,
Liu L, Su S and Mai G: Immunogenicity of COVID-19 vaccines in solid
organ transplant recipients: A systematic review and meta-analysis.
Clin Microbiol Infect. 29:441–456. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sakuraba A, Luna A and Micic D: A
systematic review and meta-analysis of serologic response following
coronavirus disease 2019 (COVID-19) vaccination in solid organ
transplant recipients. Viruses. 14(1822)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Luo D, Chen X, Du J, Mei B, Wang A, Kuang
F, Fang C, Gan Y, Peng F, Yang X, et al: Immunogenicity of COVID-19
vaccines in chronic liver disease patients and liver transplant
recipients: A systematic review and meta-analysis. Liver Int.
43:34–48. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chauhan M, Nzeako I, Li F and Thuluvath
PJ: Antibody response after a booster dose of SARS-CoV-2 vaccine in
liver transplant recipients and those with chronic liver diseases.
Ann Hepatol. 27(100702)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Strauss AT, Hallett AM, Boyarsky BJ, Ou
MT, Werbel WA, Avery RK, Tobian AAR, Massie AB, Hamilton JPA,
Garonzik-Wang JM and Segev DL: Antibody response to severe acute
respiratory syndrome-coronavirus-2 messenger RNA vaccines in liver
transplant recipients. Liver Transpl. 27:1852–1856. 2021.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Davidov Y, Tsaraf K, Cohen-Ezra O, Likhter
M, Ben Yakov G, Levy I, Levin EG, Lustig Y, Mor O, Rahav G and Ben
Ari Z: Immunogenicity and adverse effects of the 2-Dose BNT162b2
messenger RNA vaccine among liver transplantation recipients. Liver
Transpl. 28:215–223. 2022.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Odriozola A, Lamadrid-Perojo P, Cuadrado
A, San Segundo D, Del Barrio M, Fortea JI, Puente A, Amigo L,
Fernández-Santiago R, Castillo F, et al: Immune response after a
third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant
recipients. Transplantation. 106:e341–e342. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Harberts A, Schaub GM, Ruether DF,
Duengelhoef PM, Brehm TT, Karsten H, Fathi A, Jahnke-Triankowski J,
Fischer L, Addo MM, et al: Humoral and cellular immune response
after third and fourth SARS-CoV-2 mRNA vaccination in liver
transplant recipients. Clin Gastroenterol Hepatol. 20:2558–2566.e5.
2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Toniutto P, Cussigh A, Cmet S, Bitetto D,
Fornasiere E, Fumolo E, Fabris M, D'Aurizio F, Fabris C, Grillone
L, et al: Immunogenicity and safety of a third dose of
anti-SARS-CoV-2 BNT16b2 vaccine in liver transplant recipients.
Liver Int. 43:452–461. 2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sriphoosanaphan S, Suksawatamnuay S,
Srisoonthorn N, Siripon N, Thaimai P, Ananchuensook P, Thanapirom
K, Nonthasoot B, Hansasuta P and Komolmit P: Immunogenicity, immune
dynamics, and subsequent response to the booster dose of
heterologous versus homologous prime-boost regimens with adenoviral
vector and mRNA SARS-CoV-2 vaccine among liver transplant
recipients: A prospective study. Vaccines (Basel).
10(2126)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Perrier Q, Lupo J, Gerster T, Augier C,
Falque L, Rostaing L, Pelletier L, Bedouch P, Blanc M,
Saint-Raymond C, et al: SARS-CoV-2 anti-spike antibodies after a
fourth dose of COVID-19 vaccine in adult solid-organ transplant
recipients. Vaccine. 40:6404–6411. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Malinis M, Cohen E and Azar MM:
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid
organ transplant recipients. Am J Transplant. 21:2916–2918.
2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hardgrave H, Wells A, Nigh J, Klutts G,
Krinock D, Osborn T, Bhusal S, Rude MK, Burdine L and Giorgakis E:
COVID-19 mortality in vaccinated vs unvaccinated liver & kidney
transplant recipients: A single-center United States propensity
score matching study on historical data. Vaccines (Basel).
10(1921)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sandoval M, Nguyen DT, Huang HJ, Yi SG,
Ghobrial RM, Gaber AO and Graviss EA: COVID-19 mortality may be
reduced among fully vaccinated solid organ transplant recipients.
PLoS One. 17(e0279222)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
John BV, Deng Y, Khakoo NS, Taddei TH,
Kaplan DE and Dahman B: Coronavirus disease 2019 vaccination is
associated with reduced severe acute respiratory syndrome
coronavirus 2 infection and death in liver transplant recipients.
Gastroenterology. 162:645–647.e2. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dib M, Le Corre N, Ortiz C, García D,
Ferrés M, Martinez-Valdebenito C, Ruiz-Tagle C, Ojeda MJ, Espinoza
MA, Jara A, et al: SARS-CoV-2 vaccine booster in solid organ
transplant recipients previously immunised with inactivated versus
mRNA vaccines: A prospective cohort study. Lancet Reg Health Am.
16(100371)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Giannella M, Pierrotti LC, Helanterä I and
Manuel O: SARS-CoV-2 vaccination in solid-organ transplant
recipients: What the clinician needs to know. Transpl Int.
34:1776–1788. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Galmiche S, Luong Nguyen LB, Tartour E, de
Lamballerie X, Wittkop L, Loubet P and Launay O: Immunological and
clinical efficacy of COVID-19 vaccines in immunocompromised
populations: A systematic review. Clin Microbiol Infect.
28:163–177. 2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Efros O, Anteby R, Halfon M, Meisel E,
Klang E and Soffer S: Efficacy and safety of third dose of the
COVID-19 vaccine among solid organ transplant recipients: A
systemic review and meta-analysis. Vaccines (Basel).
10(95)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bailey AJM, Maganti HB, Cheng W, Shorr R,
Arianne Buchan C and Allan DS: Humoral and cellular response of
transplant recipients to a third dose of mRNA SARS-CoV-2 vaccine: A
systematic review and meta-analysis. Transplantation. 107:204–215.
2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
D'Offizi G, Agrati C, Visco-Comandini U,
Castilletti C, Puro V, Piccolo P, Montalbano M, Meschi S, Tartaglia
E, Sorace C, et al: Coordinated cellular and humoral immune
responses after two-dose SARS-CoV2 mRNA vaccination in liver
transplant recipients. Liver Int. 42:180–186. 2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ruether DF, Schaub GM, Duengelhoef PM,
Haag F, Brehm TT, Fathi A, Wehmeyer M, Jahnke-Triankowski J, Mayer
L, Hoffmann A, et al: SARS-CoV2-specific humoral and T-cell immune
response after second vaccination in liver cirrhosis and transplant
patients. Clin Gastroenterol Hepatol. 20:162–172.e9.
2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Mulley WR, Dendle C, Ling JEH and Knight
SR: Does vaccination in solid-organ transplant recipients result in
adverse immunologic sequelae? A systematic review and
meta-analysis. J Heart Lung Transplant. 37:844–852. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Cainelli F and Vento S: Infections and
solid organ transplant rejection: A cause-and-effect relationship?
Lancet Infect Dis. 2:539–549. 2002.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Vawter NL, Godino JG, Lewis SV, Northrup
AW, Samaniego JC, Poblete JY, Guereca JA, Sharp SP, Matthews E,
Crespo NC, et al: COVID-19 monoclonal antibody treatment impact on
symptoms and post-COVID conditions among high-risk patients at a
federally qualified health center. BMC Infect Dis.
23(105)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Beigel JH, Tomashek KM, Dodd LE, Mehta AK,
Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, et
al: Remdesivir for the treatment of Covid-19-final report. N Engl J
Med. 383:1813–1826. 2020.PubMed/NCBI View Article : Google Scholar
|
